Breaking News

Icosagen Acquires Carterra’s LSA Platform

The addition of the LSA increases Icosagen’s end-to-end service capabilities for drug companies developing therapeutics worldwide.

Icosagen Group, a research-driven organization providing services for the discovery and production of mammalian cell-derived biopharmaceuticals, has acquired the LSA platform from Carterra, a provider of high-throughput antibody screening and characterization solutions. Icosagen Cell Factory (ICF) has grown into a mammalian contract research, development, and manufacturing organization (CRDMO) for biopharmaceutical, biotechnology, and diagnostic industries. The company offers discovery, devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters